Back

Long-term changes in frailty and incident atrial fibrillation: multicenter prospective cohort study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk factors for atrial fibrillation and stroke prediction Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Lingli Cai

The Ninth People's Hospital, Shanghai (China)

7 More presentations in this session

Presentation thumbnail
Quo vadis, the leading arrhythmia? Projecting the prevalence of atrial fibrillation up to 2070
Doctor M. Lehto (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Temporal and age-related trends in risk factors for development of atrial fibrillation in peripartum patients
Doctor B. Ali (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Predictors of new-onset in-hospital atrial fibrillation in 122 089 patients admitted with COVID-19: an Australian statewide population study
Doctor J. Ne (Concord, AU)
Abstract Slides Video
Presentation thumbnail
Socioeconomic deprivation and atrial fibrillation risk: an observational and gene-environment interaction analysis
Doctor K. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Left atrial enlargement: a crucial indicator for identifying atrial fibrillation in patients with hypertension
Doctor X. Yi (Chongqing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors for atrial fibrillation and stroke prediction

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Frailty and cardiovascular comorbidities as predictors of short-term outcomes in HFpEF and HFmrEF patients: a retrospective cohort analysis
thumbnail
Congress Presentation
Frailty and anticoagulant prescription in older hospitalized patients with atrial fibrillation: a multi-centred observational study
thumbnail
Congress Presentation
The relaionship of frailty indices on survival in elderly patients with severe valvular heart diseases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources